Zacks Investment Research cut shares of Trupanion (NASDAQ:TRUP) from a buy rating to a hold rating in a research note released on Thursday.
According to Zacks, “Trupanion, Inc. operates as a direct-to-consumer monthly subscription service provider of a medical insurance plan for cats and dogs. It operates primarily in Canada, Puerto Rico, and the United States. The Company serves pet owners and veterinarians. Trupanion, Inc. is headquartered in Seattle, Washington. “
Other analysts have also issued reports about the company. BidaskClub lowered Trupanion from a hold rating to a sell rating in a report on Thursday. Cowen reiterated an outperform rating and set a $38.00 price target (up from $32.00) on shares of Trupanion in a report on Wednesday. CL King assumed coverage on Trupanion in a report on Tuesday, November 21st. They set a neutral rating on the stock. Northland Securities reiterated a buy rating and set a $38.00 price target on shares of Trupanion in a report on Thursday, February 8th. Finally, Stifel Nicolaus reiterated a buy rating and set a $34.00 price target (up from $33.00) on shares of Trupanion in a report on Wednesday. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and six have issued a buy rating to the company. The stock presently has a consensus rating of Buy and an average price target of $35.57.
Shares of Trupanion (TRUP) traded down $1.46 during trading on Thursday, reaching $29.68. The company had a trading volume of 731,300 shares, compared to its average volume of 332,710. The company has a market capitalization of $938.20, a price-to-earnings ratio of -494.58 and a beta of 0.34. Trupanion has a 1-year low of $13.88 and a 1-year high of $36.88. The company has a quick ratio of 1.87, a current ratio of 1.87 and a debt-to-equity ratio of 0.15.
Trupanion (NASDAQ:TRUP) last issued its quarterly earnings results on Tuesday, February 13th. The financial services provider reported ($0.05) EPS for the quarter, missing the Zacks’ consensus estimate of ($0.02) by ($0.03). The business had revenue of $66.55 million for the quarter, compared to the consensus estimate of $65.60 million. Trupanion had a negative return on equity of 6.72% and a negative net margin of 0.62%. research analysts anticipate that Trupanion will post 0.03 EPS for the current fiscal year.
In other Trupanion news, insider Asher Bearman sold 4,039 shares of the business’s stock in a transaction on Tuesday, November 21st. The stock was sold at an average price of $28.40, for a total value of $114,707.60. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Darryl Rawlings sold 3,500 shares of the business’s stock in a transaction on Wednesday, December 13th. The shares were sold at an average price of $30.10, for a total value of $105,350.00. Following the completion of the sale, the insider now owns 1,393,476 shares in the company, valued at $41,943,627.60. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 25,039 shares of company stock worth $775,403. Corporate insiders own 31.24% of the company’s stock.
Several institutional investors and hedge funds have recently modified their holdings of the business. Wells Fargo & Company MN raised its stake in shares of Trupanion by 13.5% in the second quarter. Wells Fargo & Company MN now owns 11,261 shares of the financial services provider’s stock valued at $252,000 after buying an additional 1,342 shares during the period. California Public Employees Retirement System raised its stake in shares of Trupanion by 3.7% in the second quarter. California Public Employees Retirement System now owns 42,200 shares of the financial services provider’s stock valued at $944,000 after buying an additional 1,500 shares during the period. Bank of New York Mellon Corp raised its stake in shares of Trupanion by 2.4% in the fourth quarter. Bank of New York Mellon Corp now owns 79,000 shares of the financial services provider’s stock valued at $2,311,000 after buying an additional 1,818 shares during the period. Alliancebernstein L.P. raised its stake in shares of Trupanion by 11.4% in the second quarter. Alliancebernstein L.P. now owns 18,600 shares of the financial services provider’s stock valued at $416,000 after buying an additional 1,900 shares during the period. Finally, Nationwide Fund Advisors raised its stake in shares of Trupanion by 52.7% in the second quarter. Nationwide Fund Advisors now owns 12,694 shares of the financial services provider’s stock valued at $284,000 after buying an additional 4,380 shares during the period. Hedge funds and other institutional investors own 63.79% of the company’s stock.
TRADEMARK VIOLATION WARNING: “Trupanion (TRUP) Downgraded to Hold at Zacks Investment Research” was posted by The Ledger Gazette and is the property of of The Ledger Gazette. If you are reading this story on another domain, it was illegally stolen and republished in violation of US & international copyright & trademark laws. The legal version of this story can be read at https://ledgergazette.com/2018/02/16/trupanion-trup-downgraded-to-hold-at-zacks-investment-research.html.
Trupanion, Inc provides medical insurance plans for cats and dogs throughout the United States, Canada and Puerto Rico. The Company operates in two business segments: subscription business and other business. The subscription business segment includes monthly subscriptions for its medical plan, which are marketed to consumers.
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.